stella
beta
Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs) — Stella
Home
/
Opioid-use Disorder
/
Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs)
View on ClinicalTrials.gov
Recruiting
Back to Opioid-use Disorder trials
Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs)
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(4 sites)
United States
Tampa General Hospital, Tampa, Florida
University of Maryland, Baltimore, Baltimore, Maryland
Weill Cornell Medicine, New York, New York
West Virginia University: Rockefeller Neuroscience Institute, Morgantown, West Virginia